Fundraising through the 6th Series of Warrants and Investment in Growth and Repayment of Borrowings
First written in FY2024-Q2. 2 of 4 entries say "Advanced", first in FY2024-Q3. Latest entry: FY2025.
16 other companies' latest entry also says "Achieved".
- FY2025AchievedAnnual report
「Cash used in financing activities amounted to ¥853 million. The main sources of funds were ¥300 million in proceeds from long-term borrowings and ¥265 million in proceeds from the issuance of shares upon exercise of stock acquisition rights. The main uses of funds were ¥673 million in repayments of long-term borrowings and a ¥620 million decrease in short-term borrowings.」
A total of 265,000 shares under the 6th Series Stock Acquisition Rights were exercised during the fiscal year, completing the exercise of all shares issued, including those from the previous fiscal year. The financing was carried out using proceeds from the issuance of shares for growth investment and financial improvement. - FY2025-H1AdvancedAnnual report
「During the interim consolidated accounting period, the exercise of stock acquisition rights increased stated capital and capital surplus by ¥53.043 million each. The main factor behind the increase was ¥105.540 million in proceeds from the issuance of shares upon exercise of stock acquisition rights.」
As exercise of the stock acquisition rights progressed, 107,000 shares were issued during the interim period, increasing stated capital and capital surplus by ¥53.043 million each and recording ¥105.540 million in proceeds from the issuance of shares. - FY2024-Q3AdvancedAnnual report
「1 October 2023–31 December 2023 Change in total shares issued: 10,000 shares Change in stated capital: ¥5.026 million Change in capital surplus: ¥5.026 million (Note) The increase resulted from the exercise of stock acquisition rights.」
The exercise of the 6th Series Stock Acquisition Rights resulted in the issuance of 10,000 shares during the third quarter, increasing stated capital and capital surplus by ¥5.026 million each. - FY2024-Q2First statedAnnual report
「At a Board of Directors meeting held on 18 August 2023, the company resolved to issue the 6th series of stock acquisition rights through a third-party allotment. The dilution of equity value described above is scheduled to be allocated to growth investment in existing businesses and repayment of borrowings. The company believes that expanding these businesses and improving its financial position will promote its growth into a company generating stable earnings on an ongoing basis and lead to sustained increases in shareholder value.」
The company issued the 6th Series Stock Acquisition Rights through a third-party allotment and, for the first time, described a financing policy under which the proceeds would be allocated to growth investment in existing businesses and debt repayment. The stock acquisition rights cover 300,000 shares, have an exercise price of ¥1,000 and an exercise period from 4 September 2023 to 3 September 2025. Proceeds upon full exercise are stated to be ¥300 million.